🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bo Nordenskjöld

Linköping University

ORCID: 0000-0002-2134-7586
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy”.

Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.14904
N/A
0DataRank · unranked
24 citations

Annelie Johansson, Anna Nordenskjöld, Adina Iftimi, Christina Yau, Gizeh Pérez‐Tenorio +7 more

Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature

International Journal of Cancer(2022)10.1002/ijc.33969
N/A
0DataRank · unranked
19 citations

Nancy Yu, Adina Iftimi, Nicholas P. Tobin, Laura van 't Veer, Bo Nordenskjöld +8 more

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae268
N/A
0DataRank · unranked
5 citations

Huma Dar, Anna Nordenskjöld, Gizeh Pérez‐Tenorio, Nicholas P. Tobin, Christina Yau +8 more

316P Differential long-term benefit of 2-year adjuvant tamoxifen therapy for luminal-type breast cancer: Insights from a 20-year follow-up analysis of the STO trials

Annals of Oncology(2024)10.1016/j.annonc.2024.08.257
N/A
0DataRank · unranked
0 citations

Olof Danielsson, T. Fornander, Agneta Nordenskjöld, G. Pérez Tenorio, N.P. Tobin +6 more

315P Long-term tamoxifen benefit in pre- and postmenopausal patients of high and low risk with luminal A and B breast cancer

Annals of Oncology(2024)10.1016/j.annonc.2024.08.256
N/A
0DataRank · unranked
0 citations

Huma Dar, Agneta Nordenskjöld, G. Pérez Tenorio, CC Yau, CC Benz +9 more